750
Participants
Start Date
November 10, 2015
Primary Completion Date
June 21, 2018
Study Completion Date
June 21, 2018
bimatoprost 0.03% plus timolol 0.5%
1 drop of bimatoprost 0.03% plus timolol 0.5% (GANFORT®) instilled in the affected eye once daily.
Beijing Hospital, Beijing
Xuanwu Hospital Capital Medical University, Beijing
Peking University Third Hospital, Beijing
Beijing Tongren hospital Capital Medical University, Beijing
Eye & ENT Hospital of Fudan University, Shanghai
Jiangsu Province Hospital, Nanjing
Tianjin Eye Hospital, Tianjin
Tianjin Medical University Eye Hospital, Tianjin
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Eye Hospital of Wenzhou Medical University, Wenzhou
Second Xiangya Hospital of Central South University, Changsha
Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan
Henan Provincial Eye Hospital, Henan
Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou
West China Hospital, Sichuan University, Chengdu
Lead Sponsor
Allergan
INDUSTRY